This OECD COVID-19 policy brief, a product of the Open and Innovative Government Division (OIG) of the Public Governance Directorate of the OECD, examines how and to what extent the crisis has served as a catalyst for government transformation. It draws these observations and analysis from over...

Job retention (JR) schemes have been one of the main policy tools used by a number of OECD countries to contain the employment and social fallout of the COVID-19 crisis. By May 2020, JR schemes supported about 50 million jobs across the OECD, about ten times as many as during the global...

Through social benefit programmes (SBP), governments protect individuals and families from economic and social risks, and provide a safety net for households and businesses. As governments are witnessing an increase in cases of fraud in SBPs, maintaining the effectiveness and accountability of...

In global emergencies like the coronavirus (COVID-19) pandemic, open science policies can remove obstacles to the free flow of research data and ideas, and thus accelerate the pace of research critical to combating the disease. While global sharing and collaboration of research data has reached...

The COVID-19 global health emergency and its economic and social impacts have disrupted nearly all aspects of life for all groups in society. People of different ages, however, are experiencing its effects in different ways. Based on survey findings from 90 youth organisations from 48 countries,...

Public integrity is key to a resilient response to the COVID-19 crisis, ensuring that government action benefits those in need. This crisis creates opportunities for many integrity violations and could intensify fraud and corruption, particularly in public procurement, economic stimulus packages...

The urgency of tackling COVID-19 has led governments in many countries to launch a number of short-notice and fast-tracked initiatives (e.g. calls for research proposals). Without proper co-ordination amongst ministries and agencies, they run the risk of duplicating efforts or missing...

The COVID-19 pandemic has wide implications for the socio-economic fabric worldwide. In addition to health fears, citizens are facing a host of financial uncertainties stemming from the temporary closure of businesses, schools, public facilities and quarantines, as well as instability in the...

This brief discusses the existing obstacles in developing international clinical trials that are critical to fight the COVID-19 pandemic. It provides information on relevant adaptations of regulatory requirements for clinical trials, intended to accelerate the processes, and highlights the need...